Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...
Vietnam Investment Review on MSN
BiPASS Prostate Cancer Study Begins Patient Dosing
The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing ...
Full-body MRI scans are gaining popularity, but doctors warn their benefits may not outweigh the risks for healthy, symptom-free individuals. While MRIs can detect certain cancers and abnormalities, ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U ...
In the first-ever study, Australian researchers have demonstrated the feasibility and safety of using stabilised hyaluronic ...
A viral claim says cancer can be destroyed without surgery using MRI and extreme cold. Breakthrough or hype? Here's what ...
A world-first study led by Austin Health's clinician-researchers has demonstrated the feasibility and safety of using ...
"This study is a world-first in exploring stabilised hyaluronic acid (sHA) gel's potential to improve outcomes for patients ...
On 16 January 2026, Telix Pharmaceuticals announced that the first U.S. patient had been dosed in BiPASS, a Phase 3 trial ...
By recognizing patterns in test results, AI can identify patients at risk of cancer, diabetes complications, heart disease ...
In the first-ever study, Australian researchers have demonstrated the feasibility and safety of using stabilised hyaluronic ...
Australian researchers has demonstrated that the feasibility and safety of using stabilised hyaluronic acid (sHA) gel during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback